Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD

R A O'Donnell, C Peebles, J A Ward, A Daraker, G Angco, P Broberg, S Pierrou, J Lund, S T Holgate, D E Davies, D J Delany, S J Wilson, R Djukanovic, R A O'Donnell, C Peebles, J A Ward, A Daraker, G Angco, P Broberg, S Pierrou, J Lund, S T Holgate, D E Davies, D J Delany, S J Wilson, R Djukanovic

Abstract

Background: Considerable research has been conducted into the nature of airway inflammation in chronic obstructive pulmonary disease (COPD) but the relationship between proximal airways inflammation and both dynamic collapse of the peripheral airways and HRCT determined emphysema severity remains unknown. A number of research tools have been combined to study smokers with a range of COPD severities classified according to the GOLD criteria.

Methods: Sixty five subjects (11 healthy smokers, 44 smokers with stage 0-IV COPD, and 10 healthy non-smokers) were assessed using lung function testing and HRCT scanning to quantify emphysema and peripheral airway dysfunction and sputum induction to measure airway inflammation.

Results: Expiratory HRCT measurements and the expiratory/inspiratory mean lung density ratio (both indicators of peripheral airway dysfunction) correlated more closely in smokers with the severity of airflow obstruction (r = -0.64, p<0.001) than did inspiratory HRCT measurements (which reflect emphysema severity; r = -0.45, p<0.01). Raised sputum neutrophil counts also correlated strongly in smokers with HRCT indicators of peripheral airway dysfunction (r = 0.55, p<0.001) but did not correlate with HRCT indicators of the severity of emphysema.

Conclusions: This study suggests that peripheral airway dysfunction, assessed by expiratory HRCT measurements, is a determinant of COPD severity. Airway neutrophilia, a central feature of COPD, is closely associated with the severity of peripheral airway dysfunction in COPD but is not related to the overall severity of emphysema as measured by HRCT.

References

    1. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1264-73
    1. Am J Respir Crit Care Med. 2000 Jan;161(1):9-16
    1. Am J Respir Crit Care Med. 2002 Jul 1;166(1):105-10
    1. N Engl J Med. 1978 Jun 8;298(23):1277-81
    1. Am Rev Respir Dis. 1980 Aug;122(2):265-21
    1. Am Rev Respir Dis. 1984 Nov;130(5):716-21
    1. Am Rev Respir Dis. 1985 Oct;132(4):894-900
    1. Chest. 1988 Oct;94(4):782-7
    1. Am Rev Respir Dis. 1989 Apr;139(4):980-3
    1. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):772-7
    1. Chest. 1991 Jun;99(6):1357-66
    1. Am Rev Respir Dis. 1993 May;147(5):1157-61
    1. Am J Respir Crit Care Med. 1995 May;151(5):1359-67
    1. Am J Respir Crit Care Med. 1995 Aug;152(2):653-7
    1. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1666-72
    1. Am J Respir Crit Care Med. 1996 Feb;153(2):530-4
    1. Chest. 1996 Feb;109(2):353-9
    1. Radiology. 1996 Jun;199(3):825-9
    1. Am J Respir Crit Care Med. 1997 Feb;155(2):542-8
    1. Am J Respir Crit Care Med. 1997 Mar;155(3):852-7
    1. Am J Respir Crit Care Med. 1997 Apr;155(4):1290-4
    1. Am J Respir Crit Care Med. 1997 Nov;156(5):1633-9
    1. Radiol Clin North Am. 1998 Jan;36(1):189-209
    1. Eur Respir J. 1999 Feb;13(2):252-6
    1. Am J Respir Crit Care Med. 1999 Jun;159(6):1985-91
    1. Eur Respir J. 1999 Apr;13(4):839-43
    1. Thorax. 1957 Sep;12(3):219-35
    1. Am Rev Respir Dis. 1982 Jul;126(1):54-61
    1. Am J Respir Crit Care Med. 2001 Aug 1;164(3):469-73

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner